Teladoc’s Recovery Story Is Starting to Take Shape. Should You Buy the Stock?
It could be an attractive contrarian play, but beware of the risks.
Mindfully Curated
It could be an attractive contrarian play, but beware of the risks.
SpaceX is betting that it can revolutionize the AI data center market.
Today, July 2, 2026, optimism about easing inflation and renewed accumulation lifted major tokens across the board.
In this month’s “In The Know”, Cathie Wood breaks down Kevin Warsh’s five task forces to overhaul the Fed, from quieting the daily chatter of Fed governors to cross-checking distorted government statistics against private data. She explains why Trueflation’s real-time reading of 1.75% headline inflation, less than half the official 4.2% CPI, suggests the 10-year Treasury yield could break down, and why the yield curve is behaving the way it did during the Industrial Revolution: sniffing out deflation.
The EV maker beat Q2 delivery targets and lifted its full-year outlook, signaling strong demand momentum, today, July 2, 2026.
Put these on your July to-do list ASAP.
The chipmaker’s massive rerating just met its first serious stress test.
Could this be the secret to Pfizer’s rebound strategy?
The automotive tech provider was one of the few beneficiaries of higher gas prices.
Oklo and Plug Power could be potential multibaggers.
Franklin Covey’s latest quarterly results and forward guidance disappointed investors.
Perspectives on SpaceX stock will likely change once the IPO hype dies down.
Companies in the AI sector haven’t been surefire winners for investors in 2026.
Tesla reported 2026 electric vehicle deliveries that came in ahead of consensus estimates.
A new spray-on powder developed by KAIST can stop life-threatening bleeding in about one second by instantly forming a strong gel over a wound. It works on deep and irregular injuries where conventional hemostatic products often struggle and remains ef…
Don’t panic; do this instead.
The cancer test maker still has a bright future.
SpaceX shares could see increased buying action in the near future.
The best-laid plans of mice and men (and fuel cell companies) often go astray, so investors should exercise caution.
The best-laid plans of mice and men (and fuel cell companies) often go astray, so investors should exercise caution.